Eledon Pharmaceuticals, Inc.
ELDN
$2.82
-$0.11-3.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -98.56M | -78.15M | -45.62M | -79.79M | 14.64M |
| Total Depreciation and Amortization | -- | -- | -- | 359.00K | 359.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.74M | 4.22M | -24.38M | 10.71M | -86.52M |
| Change in Net Operating Assets | -2.04M | 5.03M | 7.65M | 1.48M | 6.99M |
| Cash from Operations | -73.86M | -68.89M | -62.34M | -67.24M | -64.53M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.14M | 12.86M | 10.79M | -16.13M | -41.33M |
| Cash from Investing | 21.14M | 12.86M | 10.79M | -16.13M | -41.33M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 53.78M | 53.69M | 53.81M | 80.28M | 85.57M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 53.78M | 53.69M | 53.81M | 80.28M | 85.57M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.06M | -2.34M | 2.26M | -3.08M | -20.30M |